OnKure Therapeutics Statistics
Total Valuation
OKUR has a market cap or net worth of $41.46 million. The enterprise value is -$30.35 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OKUR has 13.55 million shares outstanding. The number of shares has decreased by -0.56% in one year.
| Current Share Class | 12.86M |
| Shares Outstanding | 13.55M |
| Shares Change (YoY) | -0.56% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 17.23% |
| Owned by Institutions (%) | 45.40% |
| Float | 5.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.54 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.45, with a Debt / Equity ratio of 0.01.
| Current Ratio | 11.45 |
| Quick Ratio | 11.26 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -207.36% and return on invested capital (ROIC) is -121.86%.
| Return on Equity (ROE) | -207.36% |
| Return on Assets (ROA) | -96.53% |
| Return on Invested Capital (ROIC) | -121.86% |
| Return on Capital Employed (ROCE) | -100.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.38M |
| Employee Count | 46 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.42% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -78.42% |
| 50-Day Moving Average | 2.96 |
| 200-Day Moving Average | 2.97 |
| Relative Strength Index (RSI) | 54.93 |
| Average Volume (20 Days) | 162,776 |
Short Selling Information
The latest short interest is 37,659, so 0.28% of the outstanding shares have been sold short.
| Short Interest | 37,659 |
| Short Previous Month | 48,380 |
| Short % of Shares Out | 0.28% |
| Short % of Float | 0.75% |
| Short Ratio (days to cover) | 0.26 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -66.68M |
| Pretax Income | -63.46M |
| Net Income | -63.46M |
| EBITDA | -66.22M |
| EBIT | -66.68M |
| Earnings Per Share (EPS) | -$4.76 |
Full Income Statement Balance Sheet
The company has $70.33 million in cash and $687,000 in debt, giving a net cash position of $69.64 million or $5.14 per share.
| Cash & Cash Equivalents | 70.33M |
| Total Debt | 687,000 |
| Net Cash | 69.64M |
| Net Cash Per Share | $5.14 |
| Equity (Book Value) | 66.43M |
| Book Value Per Share | 4.90 |
| Working Capital | 65.28M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$63.67 million and capital expenditures -$52,000, giving a free cash flow of -$63.72 million.
| Operating Cash Flow | -63.67M |
| Capital Expenditures | -52,000 |
| Free Cash Flow | -63.72M |
| FCF Per Share | -$4.70 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |